U.S., June 5 -- ClinicalTrials.gov registry received information related to the study (NCT07003386) titled 'Galantamine Improves Motor and Sensory Dysfunction in Patients With Acute Ischemic Stroke' on May 26.
Brief Summary: Although mechanical thrombectomy or thrombolytic therapy for large vessels can achieve a revascularization rate (TICI >=2b) of over 90%, 30-50% of patients still exhibit poor functional outcomes. This phenomenon of "ineffective reperfusion" suggests that microcirculatory dysfunction plays a decisive role in post-stroke neural injury. Therefore, it is necessary to combine brain protection strategies with microcirculatory reperfusion therapy to improve the functional prognosis of stroke patients.
As an acetylcholinester...